To determine whether PMAIP1 and CFLAR are direct transcriptional targets of c-Myc in TAS4464-treated AML cells, we evaluated c-Myc-binding at their promoter regions by ChIP-qPCR scanning. The gene discussed is MYC; the disease is acute myeloid leukemia.